E2F1 is another core player involved in cell cycle progression, DNA damage response, and apoptosis; therefore, E2F1 inhibition may affect different levels of tumor development by blocking cell cycle progression and impounding the metabolic flexibility of cancer cells [48]. This evidence concerns the gene E2F1 and neoplasm.